This trial will test whether CBD can be safely used alongside exposure therapy to help people with PTSD.
2 Primary · 7 Secondary · Reporting Duration: Baseline, Day 4, Day 8, Day 15 and at about 45 Days (1 month follow-up visit)
Active Control
Non-Treatment Group
28 Total Participants · 2 Treatment Groups
Primary Treatment: Cannabidiol (CBD) · Has Placebo Group · Phase 1 & 2
Participation is compensated
You will be compensated for participating in this trial.
Age 18 - 65 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Texas | 100.0% |
18 - 65 | 100.0% |
University of Texas Health Science Center at San Antonio - STRONG STAR Northwest Center | 100.0% |
Met criteria | 100.0% |